InicioBBZA • ETR
add
BB Biotech 2nd Line Ord Shs
Cierre anterior
38,20 €
Intervalo diario
37,10 € - 38,35 €
Intervalo anual
37,05 € - 51,60 €
Cap. bursátil
1972,24 M CHF
Volumen medio
22,29 mil
Relación precio-beneficio
-
Rentabilidad por dividendo
-
Bolsa de valores principal
SWX
Noticias sobre los mercados
Información sobre la empresa
BB Biotech AG is a Swiss investment company in the field of biotechnology. The company invests mainly in the United States and Western Europe and is managed by Bellevue Asset Management, a division of Bellevue Group, which is listed on the Swiss Stock Exchange.
It is one of the largest investment companies in the biotech sector. Wikipedia
Fundación
9 nov 1993
Sitio web
Empleados
86